| Rebecka Laura Belcher, SLP | |
|
31 Derickson Ln, Stanton, KY 40380-2153 | |
| (606) 663-0435 | |
| (606) 663-8040 |
| Full Name | Rebecka Laura Belcher |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 31 Derickson Ln, Stanton, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386841310 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2811 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecka Laura Belcher, SLP 307 Norwood Dr, Richmond, KY 40475-1255 Ph: (859) 608-6143 | Rebecka Laura Belcher, SLP 31 Derickson Ln, Stanton, KY 40380-2153 Ph: (606) 663-0435 |
News Archive
A new study reveals that less than an hour of training the brain could help strengthen the neural connections of the brain. This study could help develop new treatment and management strategies for progressive neurodegenerative disorders such as stroke and Parkinson's believe the researchers.
An international team of researchers has identified more than 1,200 genetic variants that are associated with how much schooling a person completes and used the findings to create a "polygenic" score that is predictive of more than 11% of the variation in education level between individuals.
Landmark tobacco legislation (Bill C-32, An Act to Amend the Tobacco Act) - passed by the Senate today - will ban flavoured cigarettes and cigarillos as well as tobacco advertising in magazines and newspapers.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
› Verified 2 days ago
Courtney Alexis Bowling, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Derickson Ln, Stanton, KY 40380 Phone: 606-663-0435 | |
Linda S Abner, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 440 Washington St, Stanton, KY 40380 Phone: 606-663-5771 Fax: 606-663-5650 | |
Charlene Nicole Skeens, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Derickson Ln, Stanton, KY 40380 Phone: 606-663-0435 | |
Speech Therapy Solutions, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 47 W Railroad St, Stanton, KY 40380 Phone: 606-663-8008 Fax: 606-663-0550 |